Outlook Therapeutics Management
Management criteria checks 2/4
Outlook Therapeutics' CEO is Russ Trenary, appointed in Jul 2021, has a tenure of 3.33 years. total yearly compensation is $1.76M, comprised of 34.1% salary and 65.9% bonuses, including company stock and options. directly owns 0.012% of the company’s shares, worth €12.70K. The average tenure of the management team and the board of directors is 3.3 years and 5.4 years respectively.
Key information
Russ Trenary
Chief executive officer
US$1.8m
Total compensation
| CEO salary percentage | 34.1% |
| CEO tenure | 3.3yrs |
| CEO ownership | 0.01% |
| Management average tenure | 3.3yrs |
| Board average tenure | 5.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$94m |
| Mar 31 2024 | n/a | n/a | -US$159m |
| Dec 31 2023 | n/a | n/a | -US$51m |
| Sep 30 2023 | US$2m | US$600k | -US$59m |
| Jun 30 2023 | n/a | n/a | -US$60m |
| Mar 31 2023 | n/a | n/a | -US$57m |
| Dec 31 2022 | n/a | n/a | -US$70m |
| Sep 30 2022 | US$1m | US$600k | -US$66m |
| Jun 30 2022 | n/a | n/a | -US$65m |
| Mar 31 2022 | n/a | n/a | -US$60m |
| Dec 31 2021 | n/a | n/a | -US$53m |
| Sep 30 2021 | US$8m | US$145k | -US$53m |
Compensation vs Market: Russ's total compensation ($USD1.76M) is above average for companies of similar size in the German market ($USD474.54K).
Compensation vs Earnings: Russ's compensation has increased whilst the company is unprofitable.
CEO
Russ Trenary (66 yo)
3.3yrs
Tenure
US$1,758,862
Compensation
Mr. C. Russell Trenary, III, also known as Russ, serves as a President, Chief Executive Officer and Director at Outlook Therapeutics, Inc., since July 06, 2021. He served as the Chief Executive Officer and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Executive Chairman | 6.6yrs | US$242.50k | 0.0025% € 2.7k | |
| President | 3.3yrs | US$1.76m | 0.012% € 12.7k | |
| Executive VP | 9.2yrs | no data | 0.025% € 27.5k | |
| Chief Commercial Officer | 6yrs | US$718.20k | 0.16% € 172.5k | |
| Senior Vice President of Licensing and M&A | 2.8yrs | no data | no data | |
| Senior Vice President of Medical Affairs | 1.8yrs | no data | no data | |
| Senior Vice President of Clinical Development & Regulatory Affairs | no data | no data | no data | |
| Senior VP - Head of Europe | less than a year | no data | no data |
3.3yrs
Average Tenure
62yo
Average Age
Experienced Management: 41O's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Executive Chairman | 6.6yrs | US$242.50k | 0.0025% € 2.7k | |
| President | 3.3yrs | US$1.76m | 0.012% € 12.7k | |
| Executive VP | 6.3yrs | no data | 0.025% € 27.5k | |
| Independent Director | 8.9yrs | US$95.00k | 0.10% € 109.4k | |
| Independent Director | 2.3yrs | US$79.00k | 0% € 0 | |
| Independent Non-Employee Director | 4.6yrs | US$112.50k | 0% € 0 | |
| Board Observer | no data | no data | no data | |
| Independent Non-Employee Director | 4.6yrs | US$79.00k | 0% € 0 | |
| Independent Director | 7.2yrs | US$113.00k | 0.014% € 15.7k | |
| Independent Director | 7.1yrs | US$110.00k | 0.013% € 14.6k | |
| Independent Director | 4.4yrs | US$75.00k | 0% € 0 |
5.4yrs
Average Tenure
63yo
Average Age
Experienced Board: 41O's board of directors are considered experienced (5.4 years average tenure).